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Background: The diagnosis of primary ciliary dyskinesia (PCD) is difficult and
requires a combination of clinical features, nasal nitric oxide testing, cilia
ultrastructural analysis by electron microscopy (EM), and genetics. A recently
described cytoplasmic ultrastructural change termed “ciliary inclusions” was
reported to be diagnostic of PCD; however, no supporting evidence of PCD was
provided. In this study, we sought to confirm, or refute, the diagnosis of PCD in
subjects with “ciliary inclusions” on EM.
Methods: Six subjects from five families with previous lab reports of “ciliary
inclusions” on EMs of ciliated cells were identified and evaluated at a Genetic
Disorders of Mucociliary Clearance Consortium site. We performed a detailed clinical
history, nasal nitric oxide measurement, genetic testing including whole‐exome
sequencing (WES), and when possible, repeat ciliary EM study.
Results: Only one of six subjects had multiple and persistent clinical features
congruent with PCD. No subject had situs inversus. Only one of six subjects had a
very low nasal nitric oxide level. No “ciliary inclusions” were found in three subjects
who had a repeat ciliary EM, and ciliary axonemal ultrastructures were normal.
Genetic testing, including WES, was negative for PCD‐causing genes, and for
pathogenic variants in gene pathways that might cause “ciliary inclusions,” such as
ciliary biogenesis.
Conclusion: “Ciliary Inclusions”, in isolation, are not sufficient to diagnosis PCD. If
seen, additional studies should be done to pursue an accurate diagnosis.
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1 | INTRODUCTION
Kartagener et al1 in 1933 described the classic clinical triad of
bronchiectasis, chronic sinusitis, and situs inversus. In the 1970s,
immotile cilia and ciliary electron microscopy (EM) defects
associated with ciliary dysfunction were found to be the under-
lying cause of defective mucociliary clearance and chronic
sinopulmonary infections in patients with Kartagener syndrome.3
Eventually, it was recognized that abnormal cilia movement, not
simply immotile cilia, can cause disease; hence, the current name
primary ciliary dyskinesia (PCD).4
Ciliary ultrastructural EM changes have traditionally been used
as the “gold standard” for diagnosis of PCD, but we now recognize
limitations to this approach.5-7 Changes in cilia ultrastructure can be
nonspecific, reflecting air pollutants and smoke exposure, or infection
and inflammation.8,9 Some patients phenotypically have PCD, but
normal cilia ultrastructure, for example, patients with mutations in
DNAH11, a PCD‐causing gene associated with a normal cilia EM.5
There have also been instances where cilia ultrastructural defects
have been initially thought to cause PCD, and later were shown to be
nonspecific, such as missing inner dynein arms in isolation, or
misalignment of the central pairs.6,10-12
The current sensitivity of cilia EM for the diagnosis of PCD is
~70%.7 Assessment of ciliary waveforms using high‐speed video
microscopy for the diagnosis of PCD is difficult to replicate, requires
a high level of skill to perform, and is not universally accepted.13-15
Recently, PCD diagnostic guidelines have stressed the use of
commercially available genetic test panels due to clinical expertise
needed for ciliary EM interpretation.16 Due to the complexities of
PCD diagnosis, a combination of clinical features, genetics, nasal
nitric oxide testing (nNO), and cilia EM are required for confident
diagnosis across the spectrum of PCD.
A recent manuscript reported an EM finding of “ciliary
inclusions” in the cytoplasm of ciliated cells as diagnostic of
PCD.17 These inclusions were reported to reflect cilia in the
cytoplasm of airway epithelial cells, because of an inability to reach
the cell surface. Although this EM finding was interpreted to be
diagnostic of PCD, there was no supporting evidence to support a
diagnosis of PCD in the reported cases, including no phenotype,
ciliary axonemal defect, clinical nNO, or genetic testing provided to
support a diagnosis of PCD. In this study, we sought to confirm, or
refute, the diagnosis of PCD in subjects with cytoplasmic “ciliary
inclusions” on EM.
2 | MATERIALS AND METHODS
Six subjects (three from the original report) were identified who had
“ciliary inclusions” reported on at least one respiratory cilia biopsy.
These subjects were evaluated at a Genetic Disorders of Mucociliary
Clearance Consortium (GDMCC) center at the University of North
Carolina (n = 4) or Children’s Hospital Colorado (n = 2). Subjects
underwent standard collection of medical history as it pertains to
PCD, which included: neonatal history; cough and sputum produc-
tion; pulmonary infections; nasal congestion and sinusitis; surgical
history; antibiotic usage; and any other pertinent medical conditions.
Nasal NO was measured using a chemiluminescence analyzer (ECO
PHYSICS AG, Duernten, Switzerland) using a previously described
technique.18 If possible, plateau measurements were used for nNO;
however, due to the young age of many of the subjects, tidal
breathing measurements were obtained when necessary. Nasal
scrape biopsy for repeat ciliary EM analysis used the previously
described GDMCC technique.5,19-21 At least 25 ciliated cells were
examined for ciliary inclusions.
Finally, blood (proband) and/or a buccal swab (family members)
was obtained for genetic analysis. Initially, a PCD gene panel of either
30 (subject #1, 2, 4, 6) or 34 (#3) PCD‐associated genes was
performed by Invitae (https://www.invitae.com/en/). The Invitae
panel consists of sequencing and analysis of coding regions and
splice junctions, as well as exon‐level deletion/duplication analysis
using next‐generation sequencing. Whole‐exome sequencing (WES)
and data analysis were then performed for two subjects (#2 and 3) at
the Yale Center for Mendelian Genomics, or at the McDonnell
Genome Institute in St. Louis on four subjects (#1, 2, 4, and 6) using
previously described methods.22 Finally, manual review of WES data
was also performed for all currently known PCD‐associated genes
(E‐Table 1).
Informed consent was obtained from the subject’s parents and
the study was approved by the University of North Carolina at
Chapel Hill and the University of Colorado Institutional Review
Boards.
3 | RESULTS
Three subjects from the original manuscript were further evaluated
(#1‐3 in Table 1), and three additional subjects reported to have
“ciliary inclusions” (#4‐6 in Table 1) were evaluated at a GDMCC
site. Clinical characteristics, including PCD‐related medical history,
and diagnostic studies are summarized in Table 1. The majority of
subjects had at least one clinical feature congruent with PCD,
including year‐round nasal congestion that started under 6 months
of age.23 No subject had a laterality defect or bronchiectasis. One
subject (#2) had three clinical characteristics associated with, but
not diagnostic of, PCD.23 Two other subjects (#1 and 6) had two
clinical features consistent with PCD when evaluated at age 3 years,
but these were not present when re‐evaluated at 5 years of age.
Nasal nitric oxide testing was performed at least once on all six
subjects (Table 1). One subject (#2) had an abnormal nNO (plateau)
value below 77 nL/min,17 but all other subjects had normal values
for age.
Subjects in the original paper (#1‐3) in Table 1 were reported to
have normal ciliary axonemal structure.17 A repeat nasal ciliary EM
was performed at a GDMCC site on three subjects (#3‐5). No “ciliary
inclusions” were found on repeat ciliary ultrastructural analysis
(Figure 1), and the ciliary axonemal structure was normal.
All unrelated subjects underwent genetic testing (n = 5). No
known mutations or pathogenic variants were found in 30 known
PCD causing genes (Table 1). All subjects were also negative for
pathogenic variants in CCNO and MCIDAS, recently described genetic
causes of PCD associated with a decreased number of cilia and
retained basal bodies and rootlets in the cytoplasm, but normal
ciliary axonemal structure.24,25 Finally, WES to identify novel PCD or
“ciliary inclusion” disease‐causing genes was also negative. Subject #3
had a large deletion of chromosome 22 on the microarray, a known
cause of Phelan‐McDermid syndrome,26 but this deletion did not























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The diagnosis of PCD is complex, and no single test is sensitive or specific
enough to be considered a gold standard for establishing a diagnosis.
Therefore, diagnosis requires patients to have compatible clinical features
of PCD along with a combination of either low nNO testing on more than
one occasion, and/or positive genetic testing, and/or positive findings on
ciliary EM.16,23,27 Recently published diagnostic guidelines from the
American Thoracic Society and the PCD Foundation have emphasized
genetic testing over EM, as EM is prone to errors in both processing and
interpretation.16,27 Regardless of what testing is done first, patients must
have a thorough clinical evaluation for PCD before testing, and all testing
must be interpreted carefully.
A recent manuscript reported a new EM finding of “ciliary inclusions”
in the cytoplasm of ciliated cells that was interpreted as being diagnostic
of PCD in six subjects. Unfortunately, no phenotypic information or other
diagnostic testing results (nNO; ciliary axonemal defect; genetics) were
provided to support the diagnosis of PCD. Therefore, we sought to
confirm, or refute, the diagnosis of PCD in subjects with cytoplasmic
“ciliary inclusions” on EM. Our studies show that at least two of the
subjects (#1 and #3 for Table 1) from that original report do not have
PCD, based on clinical phenotype and normal lab studies of ciliary
ultrastructure, nNO, and genetic testing. Further, repeat EM studies of
nasal ciliated cells in subject #3, who had Phelan‐McDermid syndrome,
did not show “ciliary inclusions.” We also studied an additional three
subjects that had been diagnosed with PCD on the basis of EM findings,
“ciliary inclusions,” but our studies did not support the diagnosis of PCD,
based on clinical phenotype and lab studies, including normal nNO,
normal cilia EM, and negative genetic testing, including WES.
The failure to demonstrate “ciliary inclusions” on repeat cilia EM in
three subjects provides further evidence against “ciliary inclusions” being
PCD‐causing. All known causes of PCD that lead to ultrastructural
changes in cilia are consistently present on repeat respiratory epithelial
tissue samples, which reflects genomic mutations, and not secondary
changes where variable findings are more common.28 We sought to
identify a genetic cause for “ciliary inclusions” or PCD, but were unable to
identify one, either in PCD‐causing genes or in ciliary biogenesis genes
that might cause “ciliary inclusions.”
The most likely etiology of “ciliary inclusions” in the cytoplasm of
ciliated cells is that they reflect technical artifacts during cellular
processing and/or EM imaging. Epithelial cells are not received in an
EM lab in well‐aligned rows but are instead in clumps with cells facing
F IGURE 1 Selected EM images from subject #4 (Table 1). Images (A, B) are from the original tracheal mucosal biopsy read as “ciliary
inclusion” disease by the authors of the Wartchow et al17 “ciliary inclusions” manuscript. Image (A) demonstrates a ciliary “inclusion” (black
arrow) with a vesicular inclusion containing proteinaceous material. Image (B) is a higher power image of a ciliary “inclusion” which, per the
Wartchow et al’s lab, demonstrates disorganized cilia within the “inclusion” (black arrow). Images (C, D) are from a repeat nasal cilia biopsy done
at a Genetic Disorders of Mucociliary Clearance Consortium site and processed and analyzed at the University of North Carolina. Image (C)
shows a respiratory epithelial cell on repeat biopsy on subject #4 without “ciliary inclusions”, and none were seen in any of the greater than 25
cells that were examined. Note that the cell surface, basal bodies, and cell nucleus are included in a single cell. Image (D) shows a normal number
of cilia present on the repeat biopsy of subject #4 (Table 1)
multiple directions (Figure 2). These cells are also not perfectly symmetric
shapes, but rather complex three‐dimensional shapes and the cell surface
is not smooth, but rather has multiple invaginations. When cells are cut
tangentially, the resulting image could give the appearance of a cilia
within the cytoplasm of the cell. Importantly, if the image does not
include the cell surface, basal bodies, and nucleus in the same image, it
cannot reliably be interpreted as a defect and could be the result of
technical artifact (Figure 1). While the original paper claims to show
entire ciliated epithelial cells, close inspection shows that none of the cells
in the figures contain cilia, an undisrupted cell surface, basal bodies, and a
nucleus in the same image.
For any new ciliary EM finding in subjects suspected of having
PCD, confirmatory testing must be done before adopting it for
general use for diagnostic purposes, because misdiagnosis of PCD
can lead to significant consequences. Patients and their families can
experience unnecessary anxiety at a new diagnosis, and delay of the
proper diagnosis may delay the initiation of appropriate therapy.27
An incorrect diagnosis of PCD can be a significant cause of harm to
patients and should be avoided.
In conclusion, we were unable to confirm a diagnosis of PCD in
any of the six patients in our study, although we were not able to rule
out PCD in one of the subjects (#2, Table 1). Therefore, “ciliary
inclusions” in isolation are not a hallmark of PCD, and patients with
“ciliary inclusions” alone should not be diagnosed with PCD. If “ciliary
inclusions” are seen on ciliary EM, other causes for the patient’s
symptoms should be investigated.
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